跳至主要内容
临床试验/NCT04358146
NCT04358146招募中不适用

Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula: a Double-blind, Randomized, Controlled, International, Multi-centric Clinical Trial

United Pharmaceuticals12 个研究点 分布在 4 个国家目标入组 346 人开始时间: 2023年3月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
346
试验地点
12
主要终点
Frequency of regurgitation

研究概览

简要总结

The aim of the study is to assess the effectiveness of this new formula on regurgitations and secondarily its effect on digestive tolerance through a randomized, controlled, double-blind trial against a comparator.

详细描述

The study duration is 1 month and 2 days. It is possible to add 2 additional months (optional).

The 2 first days (from D-3 to D0) correspond to the pre-selection period. These 2 days are followed by the follow-up month (from D0 to D30). It is possible to add an optional follow up of 2 months (form D30 to D90).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
2 Weeks 至 4 Months(Child)
性别
All
接受健康志愿者

入选标准

  • ≥ 2 regurgitation episodes per day during the last 2 weeks and ≥ 4 regurgitation episodes per day in average during the last 2 days,
  • exclusive or predominant formula feeding
  • whose parents signed informed consent

排除标准

  • preterm infants or birthweight <2500g
  • Post enteritis lactose intolerance
  • Suspected or diagnosed cow's milk protein allergy requiring an eviction diet
  • Use of medications that may interfere with regurgitation or gastrointestinal transit (such as alginates, laxatives, antibiotics...). All these medications have to be stopped at least 7 days before inclusion visit (V1)
  • Infants presenting with any situation which, according to the investigator, may interfere with the study participation, or lead to a particular risk for the subject

研究组 & 干预措施

Test

Experimental

new thickened infant formula containing fibres

干预措施: Experimental Infant formula (Other)

Control

Active Comparator

infant formula thickened with locust bean

干预措施: Infant formula thickened with locust bean gum (Other)

结局指标

主要结局

Frequency of regurgitation

时间窗: Day 14

Decrease of the daily number of regurgitation between baseline and day 14

次要结局

  • Frequency of regurgitations(Day 30, Day 90)
  • Severity of regurgitation episodes(Day 14, Day 30, Day 90)
  • Stools' frequency(Day 14, Day 30, Day 90)
  • Stools' consistency(Day 14, Day 30, Day 90)
  • Frequency of diarrhea(Day 14, Day 30, Day 90)
  • Anthropometric parameters - Weight-for-height z-score(Day 14, Day 30, Day 90)
  • Severity of diarrhea(Day 14, Day 30, Day 90)
  • Frequency of constipation(Day 14, Day 30, Day 90)
  • Severity of constipation(Day 14, Day 30, Day 90)
  • Crying time(Day 14, Day 30, Day 90)
  • Feeding refusal(Day 14, Day 30, Day 90)
  • Abnormal posturing(Day 14, Day 30, Day 90)
  • Sleep quality(Day 14, Day 30, Day 90)
  • Anthropometric parameters - Weight(Day 14, Day 30, Day 90)
  • Anthropometric parameters - Length(Day 14, Day 30, Day 90)
  • Anthropometric parameters - Head circumference(Day 14, Day 30, Day 90)
  • Anthropometric parameters - BMI(Day 14, Day 30, Day 90)
  • Use of drug treatments(Day 14, Day 30, Day 90)
  • Parents' satisfaction(Day 14, Day 30, Day 90)
  • Investigator's satisfaction(Day 14, Day 30, Day 90)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验